In this webinar we present a condensed review of the last 15 years of launched small molecules. We look at market consumption, resulting volumes of API and how CMOs need to be investing in their manufacturing assets in order to supply pharmaceutical innovators with the required volumes.
Dr. Matthew Moorcroft, VP of Global Marketing, Cambrex
Joshua Van Kley, Sales Operations Manager, Cambrex
Bjarne Sandberg, Managing Director, Cambrex Karlskoga